Bharat Parenterals Ltd

NSE: BPLPHARMA · BSE: 541096 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹1,839.20
Market cap: ₹1,268 Cr
Revenue (annual): ₹345.4 Cr
Net profit (annual): ₹-8.19 Cr
P/E (TTM): 1019.1×Sector 43.8×
Promoter holding: 67.20%+0.00% QoQ
FII holding: 0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 3 Earnings Call 2 Board Meeting Date 2 Preferential Issue 1 Other Announcement 1 Management Change 1 Fund Raise 1 Financial Results 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

2 Nov 2026 15:55 IST BSE

Earnings Call

Bharat Parenterals Earnings Call Transcript: Key Takeaways

Q2 FY27 consolidated revenue ₹136.3 Cr (+110% YoY, +45% QoQ) and PAT ₹11.8 Cr, the first group profit quarter, led by Innoxel. Standalone margins squeezed by input costs; FY27 guidance maintained.

Open call summary → Read the filing ↗

29 Oct 2026 17:14 IST BSE

Earnings Call

Bharat Parenterals Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue ₹136.3 Cr (+110.9% YoY), EBITDA ₹23.6 Cr (17.3%), PAT ₹11.8 Cr; Innoxel turned profitable.

Open call summary → Read the filing ↗